Valuation: Progyny, Inc.

Market Cap 1.94B 1.72B 1.61B 1.46B 2.76B 186B 2.79B 19.43B 7.53B 95.13B 7.27B 7.11B 305B P/E 2026 *
19.6x
P/E 2027 * 16.6x
Enterprise Value 1.77B 1.57B 1.47B 1.34B 2.52B 170B 2.54B 17.74B 6.88B 86.9B 6.64B 6.49B 279B EV / Sales 2026 *
1.29x
EV / Sales 2027 * 1.04x
Free-Float
75.41%
Yield 2026 *
-
Yield 2027 * -
1 day+0.28%
1 week-0.72%
Current month+0.58%
1 month-6.69%
3 months-18.09%
6 months+50.98%
Current year-1.34%
1 week 24.33
Extreme 24.33
25.49
1 month 24.33
Extreme 24.33
27.98
Current year 16.1
Extreme 16.1
33.06
1 year 16.1
Extreme 16.1
33.06
3 years 13.39
Extreme 13.39
42.08
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 31/12/2021
Director of Finance/CFO 60 14/09/2020
Chief Operating Officer 56 16/04/2025
Director TitleAgeSince
Chairman 66 31/12/2021
Director/Board Member 77 15/12/2016
Director/Board Member 58 31/12/2021
Date Insider Type Main position Quantity % Market Cap. Importance
23/09/26 Sell

General Counsel

-3,903 0.0051%
17/09/26 Tax

Executive/Senior Manager

-819 0.0011%
10/09/26 Exercice

Director

66,000 0.0860%
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%-0.72%+25.48%-23.99% 1.94B
-0.26%-1.84%+3.38%-28.15% 334B
+1.19%-1.00%+11.64%-11.99% 83.8B
-0.18%-0.81%-11.02%-5.51% 71.48B
+0.96%+0.28%+32.35%-20.10% 46.63B
+0.87%+1.79%+69.10%-7.78% 31.12B
+0.94%+0.84%-4.66%-41.89% 9.87B
+10.83%+16.65%+14.82%+41.64% 7.83B
+3.31%+3.93%+71.76%+324.53% 2.33B
+3.09%+3.53%-52.02%+14.35% 1.65B
Average +2.10%-0.78%+16.08%+24.11% 59.05B
Weighted average by Cap. +0.31%-1.19%+8.76%-19.19%

Financials

2026 *2027 *
Net sales 1.37B 1.22B 1.14B 1.04B 1.96B 132B 1.98B 13.79B 5.35B 67.55B 5.16B 5.05B 217B 1.51B 1.34B 1.25B 1.14B 2.16B 145B 2.18B 15.18B 5.88B 74.32B 5.68B 5.55B 239B
Net income 106M 94.42M 88.13M 80.33M 151M 10.22B 153M 1.07B 413M 5.22B 399M 390M 16.76B 125M 111M 104M 94.74M 179M 12.05B 180M 1.26B 487M 6.16B 471M 460M 19.77B
Net Debt -168M -149M -139M -127M -239M -16.12B -241M -1.68B -652M -8.24B -629M -616M -26.44B -358M -318M -297M -271M -510M -34.41B -515M -3.59B -1.39B -17.59B -1.34B -1.31B -56.45B
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
05/10/26 US$25.33 +0.40% 196,064
02/10/26 US$25.23 +1.53% 939,645
01/10/26 US$24.85 -1.35% 1,587,451
30/09/26 US$25.19 +1.61% 980,453
29/09/26 US$24.79 -2.86% 1,551,987
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
25.23USD
Average target price
34.42USD
Spread / Average Target
+36.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGNY Stock